Skip to main content
Watch Insiders
BCAXHealthcare

Bicara Therapeutics Inc. (BCAX) Insider Trading

In the last 90 days, 3 Bicara Therapeutics Inc. (BCAX) insiders reported no open-market purchases and 4 sales totaling $1,554,589. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 8, 2026Ryan CohlheppPresident, COO & Interim CEOSale17,500$22.90$400,715
Aug 10, 2026Ivan HyepChief Financial OfficerSale12,500$27.97$349,591
Aug 10, 2026Claire MazumdarChief Executive OfficerSale10,000$27.98$279,750
Aug 10, 2026Ryan CohlheppPresident and COOSale18,750$27.98$524,533
Jul 10, 2026Claire MazumdarChief Executive OfficerSale10,000$28.42$284,198
Jul 9, 2026Ryan CohlheppPresident and COOSale28,750$28.98$833,129
Jul 8, 2026Ivan HyepChief Financial OfficerSale28,000$28.85$807,671
May 21, 2026Ivan HyepChief Financial OfficerSale9,200$20.42$187,883
May 18, 2026Claire MazumdarChief Executive OfficerSale15,000$20.04$300,579
May 15, 2026Ryan CohlheppPresident and COOSale12,500$20.29$253,649
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

BCAX insider trading FAQ

Are BCAX insiders buying or selling?
Over the last 90 days, BCAX insiders were net sellers, reporting $0.00 of open-market purchases and $1,554,589 of sales.
When was the last BCAX insider purchase?
No open-market insider purchase of Bicara Therapeutics Inc. stock was reported in the last 90 days.
Where does BCAX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Bicara Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.